Antitumor agent-23

Antitumor agent-23 demonstrates potent antitumor activity with GI50 values in the nanomolar range against a panel of lymphoma cell lines. This small molecule is a valuable research tool for investigating oncogenic pathways and evaluating efficacy in both in vitro and in vivo cancer models.